Analysis: Journalists often didn't communicate uncertainty of evidence on unproven COVID drugs Scientific evidence of the efficacy of the unproven COVID-19 therapies hydroxychloroquine, remdesivir, and convalescent plasma was often presented in US news stories in the first months of the pandemic, but scientific uncertainty was commonly omitted and only rarely appeared in headlines or ledes, with possible implications for public health, researchers reported yesterday in JMIR Infodemiology. CIDRAP

...

Mosquito-borne illnesses are rising: Here's how to protect yourself Mosquitos love heat. And as summers get warmer, mosquito-borne illnesses are rising, in the U.S., Europe, and South and Central America. Here are some tips to protect yourself. NPR

...

Here’s what you need to know about protecting yourself from a potentially infectious mosquito bite.

Summer COVID surge shows we may have to return to 2020 pandemic measures As the summer of 2024 draws to a close, the United States finds itself once again grappling with a surge in COVID-19 infections. ckulat The Hill

... where do we realistically go from here, given that it is clear that COVD-19 is far from over? While much progress has been made in terms of vaccination and treatment, the current surge is a stark reminder that complacency is not an option. The road ahead will require a renewed commitment to public health, both from government leaders and from individuals.

Nigeria receives 10,000 doses of mpox vaccines from US

ABUJA, Aug 29 (Reuters) - Nigeria has received 10,000 doses of the mpox vaccine from the U.S. Agency for International Development (USAID), the first batch of the vaccine to reach the country which has confirmed 40 cases with no fatalities so far.

ALSO SEE: Africa's mpox response is less than 10% funded, says Africa CDC